CEL-SCI Corporation (NYSE AMEX: CVM) announced that the Company held a clinical investigator meeting during the week of November 14th for its Phase III clinical trial of Multikine®, the Company’s flagship immunotherapy…
Tag: Corona
Researchers Discover New Function Of Gene In Promoting Cancer
Researchers at Virginia Commonwealth University have discovered that a gene well known for its involvement in tumor cell development, growth and metastasis also protects cancer cells from being destroyed by chemotherapy. By…
THE MEDICAL PROBLEMS OF AIRPORT SCREENING; IT’S NOT JUST THE RADIATION
The radiation dose is likely the least of the problems with airport screening. If operating as specified, a scanner delivers about 0.01 millirad of radiation, or 0.00001 rad. You unavoidably get 10,000…
Study Finds High-Risk Neuroblastoma More Likely In Blacks, Native Americans
An analysis of more than 3,500 children with neuroblastoma showed that blacks and Native Americans were more likely to have high-risk, aggressive disease than whites. Both groups also had worse survival –…
Fecal Immunochemical Testing Is The Best And Most Cost-Effective Method For Screening For Colorectal Cancer
Annual screening by fecal immunochemical testing-a test that detects blood in the stool, has high sensitivity and specificity, and might improve participation rates through increased patient acceptability-reduces the risk of colorectal cancer…
Look Out For Lung Cancer Symptoms Warns Royal Pharmaceutical Society
New research from the Royal Pharmaceutical Society for Lung Cancer Awareness Month shows a low awareness of the key symptoms of lung cancer, the UK’s biggest cancer killer. In the season of…
Teams Reconstruct A Cancer Cell’s Beginning In The Test Tube
What prompts normal cells to transform themselves into cancerous cells? Researchers from Texas institutions, including the UT Health Science Center San Antonio, have identified factors in the very first step of the…
Method To Trick Cancer Cells To Self-Destruct Show Promise In Mice
Tulane University researcher W T. Godbey has developed a treatment for cancer using a method that causes cancer cells to self-destruct while sparing surrounding healthy cells. While clinical trials with human patients…
Spectral Molecular Imaging Reaffirms Commitment To Early Detection Of Melanoma By Hyperspectral Imaging
Cascade Technologies, Corp. (OTCBB: CSDT) announced today that, in response to significant recent attention to the Food and Drug Administration (FDA) panel evaluation of Mela Sciences’ (Nasdaq: MELA) MelaFindTM device, the company…
JAK3 Pathway Highlighted As Leukemia Target
An intriguing study published in Expert Review of Anticancer Therapy has revealed that the signaling protein JAK3 represents a viable target in the treatment of a broad range of B-lineage cancers, including…
DRDO to train doctors to handle victims of chemical, nuclear strikes
In the wake of chemical and nuclear threats, the Institute of Nuclear Medicine and Allied Sciences (INMAS) of Defence Research and Development Organisation (DRDO) is strengthening its chemical, biological, radiological and nuclear…
Cough Medicine Could Help Doctors Identify How Breast Cancer Patients Metabolise Tamoxifen, Enabling Them To Improve Individual Treatments
Cough medicine could be used as way of predicting how well individual patients metabolise tamoxifen used in the treatment of their breast cancer, according to new research presented at the 22nd EORTC-NCI-AACR…
Common For Patients To Undergo Multiple Cardiac Imaging Tests, Which Are Associated With High Cumulative Radiation Dose
Multiple testing with the cardiac diagnostic imaging technique of myocardial perfusion imaging is common, and in many patients is associated with a high cumulative estimated radiation dose, according to a study in…
Gene Therapy For Metastatic Melanoma In Mice Produces Complete Remission
A potent anti-tumor gene introduced into mice with metastatic melanoma has resulted in permanent immune reconfiguration and produced a complete remission of their cancer, according to an article to be published in…
Combination Therapy Improves Survival Time For Patients With Advanced Liver Cancer
Treatment of inoperable advanced liver cancer with the agent doxorubicin (routinely used to treat this condition) in addition to the agent sorafenib resulted in greater overall survival and progression-free survival, compared to…